Literature DB >> 35616656

Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia.

Emily A Siegrist1, Joseph Sassine2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35616656     DOI： 10.1007/s00134-022-06754-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   41.787


× No keyword cloud information.
  1 in total

1.  Correction to: Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial.

Authors:  Adrien Bouglé; Sophie Tuffet; Laura Federici; Marc Leone; Antoine Monsel; Thomas Dessalle; Julien Amour; Claire Dahyot-Fizelier; François Barbier; Charles-Edouard Luyt; Olivier Langeron; Bernard Cholley; Julien Pottecher; Tarik Hissem; Jean-Yves Lefrant; Benoit Veber; Matthieu Legrand; Alexandre Demoule; Pierre Kalfon; Jean-Michel Constantin; Alexandra Rousseau; Tabassome Simon; Arnaud Foucrier
Journal:  Intensive Care Med       Date:  2022-07       Impact factor: 41.787
  1 in total
  1 in total

1.  Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Reply of the Editor in Chief.

Authors:  Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2022-06-06       Impact factor: 41.787
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.